140 related articles for article (PubMed ID: 16040209)
1. Myocardial infarction risk and hormone replacement: differences between products.
de Vries CS; Bromley SE; Farmer RD
Maturitas; 2006 Feb; 53(3):343-50. PubMed ID: 16040209
[TBL] [Abstract][Full Text] [Related]
2. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.
Renoux C; Dell'aniello S; Garbe E; Suissa S
BMJ; 2010 Jun; 340():c2519. PubMed ID: 20525678
[TBL] [Abstract][Full Text] [Related]
3. Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998.
Ferrara A; Quesenberry CP; Karter AJ; Njoroge CW; Jacobson AS; Selby JV;
Circulation; 2003 Jan; 107(1):43-8. PubMed ID: 12515741
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.
Psaty BM; Smith NL; Lemaitre RN; Vos HL; Heckbert SR; LaCroix AZ; Rosendaal FR
JAMA; 2001 Feb; 285(7):906-13. PubMed ID: 11180734
[TBL] [Abstract][Full Text] [Related]
5. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study.
Varas-Lorenzo C; García-Rodríguez LA; Perez-Gutthann S; Duque-Oliart A
Circulation; 2000 Jun; 101(22):2572-8. PubMed ID: 10840007
[TBL] [Abstract][Full Text] [Related]
7. Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations.
Schneider C; Jick SS; Meier CR
Climacteric; 2009 Oct; 12(5):445-53. PubMed ID: 19565370
[TBL] [Abstract][Full Text] [Related]
8. Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up.
Alexander KP; Newby LK; Hellkamp AS; Harrington RA; Peterson ED; Kopecky S; Langer A; O'Gara P; O'Connor CM; Daly RN; Califf RM; Khan S; Fuster V
J Am Coll Cardiol; 2001 Jul; 38(1):1-7. PubMed ID: 11451256
[TBL] [Abstract][Full Text] [Related]
9. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
Beral V; Bull D; Reeves G;
Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
[TBL] [Abstract][Full Text] [Related]
10. The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women.
Thompson SG; Meade TW; Greenberg G
J Epidemiol Community Health; 1989 Jun; 43(2):173-8. PubMed ID: 2592907
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer and hormone-replacement therapy in the Million Women Study.
Beral V;
Lancet; 2003 Aug; 362(9382):419-27. PubMed ID: 12927427
[TBL] [Abstract][Full Text] [Related]
12. Tibolone and endometrial cancer: a cohort and nested case-control study in the UK.
de Vries CS; Bromley SE; Thomas H; Farmer RD
Drug Saf; 2005; 28(3):241-9. PubMed ID: 15733028
[TBL] [Abstract][Full Text] [Related]
13. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal hormone use in women with acute coronary syndromes.
Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM;
J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702
[TBL] [Abstract][Full Text] [Related]
15. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and risk of non-fatal stroke.
Pedersen AT; Lidegaard O; Kreiner S; Ottesen B
Lancet; 1997 Nov; 350(9087):1277-83. PubMed ID: 9357407
[TBL] [Abstract][Full Text] [Related]
17. Post menopausal hormone replacement therapy and risk of acute myocardial infarction--a case control study of women in the East Midlands, UK.
Chilvers CE; Knibb RC; Armstrong SJ; Woods KL; Logan RF
Eur Heart J; 2003 Dec; 24(24):2197-205. PubMed ID: 14659771
[TBL] [Abstract][Full Text] [Related]
18. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.
Psaty BM; Heckbert SR; Atkins D; Lemaitre R; Koepsell TD; Wahl PW; Siscovick DS; Wagner EH
Arch Intern Med; 1994 Jun; 154(12):1333-9. PubMed ID: 8002685
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy use and the risk of stroke.
Renoux C; Dell'aniello S; Garbe E; Suissa S
Maturitas; 2008 Dec; 61(4):305-9. PubMed ID: 18996656
[TBL] [Abstract][Full Text] [Related]
20. Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome?
Ruigómez A; García Rodríguez LA; Johansson S; Wallander MA
Maturitas; 2003 Feb; 44(2):133-40. PubMed ID: 12590009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]